Abstract
Hypergonadotropic amenorrhea of youth patients is clinically defined as a premature ovarian failure in women before 40 years of age. Laboratorial exams show high FSH and low estradiol levels. Incidence in female population is 0.9%. The etiology can be divided in four great groups: acceleration of the atresia follicular, blockade of the secretion function, mixed mechanism as in the autoimmune diseases and idiopatic form. Women with primary amenorrhea and premature ovarian failure, don\'t have ovulation. Among those with secondary amenorrhea, rare cases of spontaneous return of the ovulation are observed and even if, pregnancy. It is important to do appropriate diagnosis as soon as possible, should be done at least two measures of serum gonadotropins, always discarding other associated diseases. Organic and emotional aspects of patients should be evaluated.

Key words
amenorréia hipergonadotrófica, falência ovariana precoce, hipogonadismo hipergonadotrófico, infertilidade

Bibliografía del artículo

1. Andrade, RP. Falência Ovariana Precoce. Reprod Clim 2001; 16 (2):14-18.
2. Bagnoli RV, Hayashida SA, Fonseca AM, Halbe HW. Estados Intersexuais: Disgenesia Gonadal. In: Halbe HW. Tratado de Ginecologia. São Paulo: Roca; 2000. 1600 p.
3. Halbe HW, Bagnoli VR, Cunha DC. Menopausa precoce. In: Halbe HW. Tratado de Ginecologia. São Paulo: Roca; 2000. 1600p.
4. Rebbar RW, Cannolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil. Steril. 1990; 53:804-10.
5. Martin-Du Pan RC, Dahoun S, Stalberg A, Campana A Primary amenorrhea and arterial hypertension in a case of 17 alpha-hydroxylase deficiency. J Gynecol Obstet Biol Reprod 1994; 23 (2):137-40.
6. Check JH. Ovulation induction and pregnancy with an estrogen-gonadotropin stimulation technique in a menopausal woman with marked hypoplastic ovaries. Am J Obstet Gynec 1989; 160:405.
7. Ferreira JAS, Wehba S. Avaliação do eixo hipotálamo-hipófise-ovário. In: Oliveira HC e Lemgruber I. Tratado de Ginecologia Febrasgo. Rio de Janeiro:Revinter; 2001, 237-43.
8. Yanase T, Sanders D, Shibata A, Matsui N, Simpson ER, Waterman MR. Combined 17αhydroxylase/17,20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochromoe P450 17α (CYP 17) gene. J Clin Endocrinol Metab 1990; 70(5): 1325-9.
9. Hall J, Gilchrist DM. Turner syndrome and its variants. Current issues in pediatric and adolescent endocrinology. Pediat Clin N Amer 1990; 37(6):1421-40
10. Haaq CM & Donahoe PK Regulation of dimorphism in mammals. Physiological reviews. American Physiological Society 1998; 78(1):1-33
11. Sutherland GR & Mulley JC Fragile X syndrome and others causes of X-linked mental handicap. In: Emery and Rimoin\'s. Principles and Practice of Medical Genetics. 3ª ed. NY: Churchill Livingstone; 1997. 1745-66
12. Speroff L, Glass RH e Kase NG. Desenvolvimento sexual normal e anormal. In: Speroff et al. Endocrinologia ginecológica clínica e infertilidade.5ª ed. São Paulo: Manole; 1995. p331-73.
13. Di Cerbo A, Biason LA, Savino M, Piemontese MR, Di Giorgi A, Perona M, Savoia A. Combined 17 alpha-hydroxylase/17-20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J Clin Endocrinol Metab 2002; (2):898-905.
14. Sasano H, Masuda T, Ojima M, Fukuchi S, Sasano N. Congenital 17alpha-hydroxylase deficiency: a clinicopathologic study. Hum Pathol 1987; 18(10):1002-7.
15. Scaroni C, Opocher G, Mantero F. Renin-angiotensin-aldosterone system: a long-term follow-up study in 17 alpha-hydroxylase deficiency syndrome. Clin Exp Hypert 1986; 8(4-5):773-80.
16. Saruta T, Kondo K, Saito I, Nagahama S, Suzuki H, Konishi K, Matsuki S. Control of aldosterone in 17 alpha-hydroxylase deficiency. Horm Res 1980; 13(2):98-108.
17. Yanase T, Kagimoto M, Matsui N, Simpson ER, Waterman MR. Combined 17 alpha-hydroxylase/17,20-lyase deficiency due to a stop codon in the N-Terminal region of 17 alpha-hydroxylase cytochrome P-450. Mol Cell Endocrinol. 1998; 59(3):249-53.
18. Bradshaw KD, Waterman MR, Couch RT, Simpson ER, Zurber MX. Characterization of complementary deoxyribonucleic acid for human adrenocortical 17 alpha-hydroxylase: a probe for analysis of 17 alpha-hydroxylase deficiency. Mol Endocrinol. 1987; 1(5):348-54.
19. Cottrell DA, Bello FA, Falko. 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism . Am J Med Sci 1990; 300 (6):380-2.
20. Yanase T. 17alpha-Hydroxylase/17,20-lyase defects. J Steroid Biochem Mol Biol 1995; 53(1):153-7.
21. New ML, Lorenzen F et al Genotyping steroid 21-hydroxilase deficiency: hormonal reference data. J Clin. Endocrinol. Metab. 1983; 57: 320-6.
22. Nakagome Y, Nagafushi S & Nakahori Y Mapping the human Y chromosome. Basic and Clinical Approach to Turner syndrome. In: Proceedings of the 3rd International Symposium on Turner Syndrome. Tokyo, Japan: Hibi I & Takano K Excerpta Medica; 1993. p.33-7
23. Ferguson-Smith MA. Genotype-phenotype correlations in the Turner syndrome. Basic and Clinical Approach to Turner syndrome. In: Proceedings of the 3rd International Symposium on Turner Syndrome. Tokyo, Japan: Hibi I & Takano K Excerpta Medica; 1993. p.17-32
24. Biglieri EG. 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 1997; 82 (1): 48-50.
25. Scaroni C, Biason A, Carpene G, Opocher G, Mantero F. 17 alpha-hydroxylase deficiency in three siblings: short-and long-term studies. J Endocrinol Invest 1991; 14(2):99-108.